NovaBay Pharmaceuticals A Ground Floor Opportunity, Analyst Expects 1350% Upside ($NBY)
NovaBay Pharmaceuticals Inc. (AMEX: NBY) stock is presenting a ground floor investment opportunity, so says an analyst at Ascendient Capital, who expects an over 1350% increase from current levels to $12 a share. That forecast isn’t blind ambition. The case is made after factoring in expected revenue increases, aggressive cost cutting, and faster market penetration by its innovative consumer eye, skin, and wound care products. (* share price from NASDAQ.com, 6/28/23, 9:52 AM EST) Reaching that bullish $12 price target
NovaBay Pharmaceuticals A Ground Floor Opportunity, Analyst Expects 1350% Upside ($NBY) Read More »


